Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 04, 2026
Nebius Group (NBIS): Volatility and Momentum in the AI Infrastructure Space

Nebius Group (NBIS): Volatility and Momentum in the AI Infrastructure Space

Key Takeaways

  • Nebius Group shares closed at $212.58 on August 3, 2026, reflecting a modest 1.4% decline over the prior 30 days but masking extreme intra-period volatility that saw the stock swing between roughly $148 and $261.
  • First-quarter 2026 revenue surged 684% year-over-year to $399 million, comfortably beating analyst estimates and reinforcing the company's position as one of the fastest-growing AI neocloud providers.
  • A newly announced asset-light infrastructure partnership model, a $775 million senior secured debt facility, and a more-than-$1 billion compute contract with Reflection AI all unfolded within the last 30 days.
  • Investor sentiment remains divided between bulls pointing to over $40 billion in contracted revenue backlog from investment-grade customers and bears citing $20–25 billion in planned 2026 capital expenditures and insider selling exceeding $140 million.
  • Q2 2026 earnings are expected around August 12, with analysts forecasting revenue of approximately $578 million and a narrower adjusted loss per share.

Recent Market Performance for Nebius Group (NBIS)

Nebius Group (NBIS) stands out as one of the more volatile names in the AI infrastructure sector this year. After a strong 230% rally in the first half of 2026 that took shares to an all-time high near $300 in mid-June, the stock pulled back sharply amid valuation concerns and sector rotation. From mid-June through late July it lost more than half its value, reaching a low of $148.22 on July 29 before rebounding above $212 by August 3. Even with the swings, the stock is still up roughly 110% year-to-date, which highlights both the strong interest and the caution surrounding pure-play AI infrastructure companies.

Business Overview and Competitive Position

Nebius Group N.V., based in Amsterdam and listed on Nasdaq, operates as an AI cloud provider focused on full-stack infrastructure for artificial intelligence workloads. The company rebranded from Yandex N.V. in August 2024 to emphasize its shift toward AI-native services. Its main offering, Nebius AI Cloud, delivers large-scale GPU clusters along with a proprietary platform and tools for model training, fine-tuning, and deployment. The group also includes Avride for autonomous vehicles and TripleTen for edtech, plus equity stakes in ClickHouse and Toloka.

What sets Nebius apart from hyperscalers such as AMZN-backed AWS and MSFT Azure is its GPU-centric approach and its partnership with NVDA, which invested $2 billion. With more than $40 billion in contracted revenue from investment-grade customers including META and MSFT, Nebius has moved quickly into a meaningful role among neocloud providers, competing with names such as CRWV (CoreWeave). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Developments Shaping the Narrative

The past 30 days brought several notable updates. On July 15 the company introduced an asset-light infrastructure partnership model that lets third-party data center operators host Nebius’s AI cloud platform in their facilities, with partners handling hardware ownership while Nebius provides software and demand. Two days later, Nebius closed an approximately $775 million senior secured debt facility backed by GPU assets and contracted cash flows, priced at SOFR plus 2.50% and maturing in October 2030. On the demand front, a more-than-$1 billion compute agreement with Reflection AI through 2029 bolstered the backlog.

Analyst moves included Freedom Capital’s Paul Meeks upgrading the stock to “Buy” with a $200 target on July 20 and Northland Securities lifting its target to $410. Offsetting some of the positive signals were reports of insider selling totaling more than $140 million by executives including the CEO and CTO, plus broader sector pressure from rising credit-default-swap costs and Meta’s plans to commercialize surplus capacity. The July 29 low captured those concerns before renewed buying interest lifted the shares back above $210. From what I see, these developments have added both opportunities and questions for investors.

2026 Outlook and Key Items to Monitor

The second half of the year brings several catalysts. Q2 2026 earnings are expected around August 12, with analysts projecting revenue near $578 million and a narrower adjusted loss per share. Investors will focus on GPU utilization, adjusted EBITDA margins, progress on capacity in Finland and Pennsylvania, and any updates to full-year revenue guidance of $3.0–$3.4 billion.

Over the longer term, execution on the $20–$25 billion capital expenditure plan without excessive dilution or leverage remains central. The new asset-light model could improve capital efficiency if it gains traction, while the $40-billion-plus backlog offers visibility. Risks include potential softening in spot GPU pricing, contract ramp delays, or increased competition from hyperscalers and peers such as CRWV. Macro factors like interest rates and credit conditions also matter for a company scaling infrastructure at this level. I’m watching this closely as one of the higher-beta names in the AI theme.

Leveraging Tickeron’s AI Trading Bots

In fast-moving markets like AI infrastructure, where sentiment can shift quickly, I find automated strategies helpful for maintaining discipline. Tickeron’s Trending AI Robots page highlights a selection of top-performing AI trading bots drawn from hundreds of systems. Each bot is differentiated by strategy, timeframe, and performance metrics, providing a useful complement to fundamental analysis when evaluating names such as NBIS.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NBIS

NBIS in +18.55% Uptrend, rising for three consecutive days on August 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NBIS advanced for three days, in of 138 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NBIS's RSI Oscillator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NBIS just turned positive on August 03, 2026. Looking at past instances where NBIS's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

NBIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on August 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NBIS as a result. In of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NBIS moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NBIS crossed bearishly below the 50-day moving average on July 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NBIS entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NBIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.658) is normal, around the industry mean (5.731). NBIS has a moderately high P/E Ratio (73.313) as compared to the industry average of (29.187). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (32.393). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (57.471) is also within normal values, averaging (70.644).

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Bilibili (NASDAQ:BILI).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 146.87B. The market cap for tickers in the group ranges from 2.69K to 4.37T. GOOGL holds the highest valuation in this group at 4.37T. The lowest valued company is STBXF at 2.69K.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -5%. AREN experienced the highest price growth at 35%, while ONFO experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 94
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
NBIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an investment holding company with interest in providing internet search engine services

Industry InternetSoftwareServices

Profile
Details
Industry
Internet Software Or Services
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.